| Prenatal molecular diagnosis of RET proto-oncogene mutation in multiple endocrine neoplasia type 2A. | None |
| Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2. | None |
| Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. | None |
| Detection of RET proto-oncogene codon 634 mutations using mass spectrometry. | None |
| Sequence and characterisation of the RET proto-oncogene 5 flanking region: analysis of retinoic acid responsiveness at the transcriptional level. | None |
| Cys 634 mutations in the RET proto-oncogene in Spanish families affected by MEN 2A. | None |
| Duplication of 9 base pairs in the critical cysteine-rich domain of the RET proto-oncogene causes multiple endocrine neoplasia type 2A. | None |
| Occurrence of MEN 2a in familial Hirschsprung s disease: a new indication for genetic testing of the RET proto-oncogene. | None |
| Multiple endocrine neoplasia 2B with glaucoma associated with codon 918 mutation of the RET proto-oncogene. | None |
| RET proto-oncogene mutation analysis for multiple endocrine neoplasia, type 2. | None |
| Presence of the 918 mutation in the RET proto-oncogene in a Mexican patient with multiple endocrine neoplasia type 2B. | None |
| [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers]. | None |
| Prognostic value of RET proto-oncogene point mutations in malignant and benign, sporadic phaeochromocytomas. | None |
| Germline RET proto-oncogene mutations in two Taiwanese families with multiple endocrine neoplasia type 2A. | None |
| Expression of the RET proto-oncogene in human embryos. | None |
| High prevalence of the C634Y mutation in the RET proto-oncogene in MEN 2A families in Spain. | None |
| [Ret (REarranged during Transfection). Oncogene]. | None |